Display Settings:


Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Semin Oncol. 2006 Dec;33(6 Suppl 11):S70-4.

Can pelvic radiotherapy be omitted in select patients with rectal cancer?

Author information

  • 1Division of Surgery, City of Hope National Medical Center, Duarte, CA, USA.


Randomized prospective trials have shown the benefits of adjuvant radiotherapy in decreasing local recurrence rates in stage II and stage III rectal cancer. However, some patients with stage II lesions have relatively low risks of local recurrence when treated with modern surgery alone. This article will discuss important prognostic, diagnostic, and therapeutic factors including depth of tumor invasion, tumor location, improvements in staging with endorectal ultrasound and magnetic resonance imaging, enhanced surgical technique with total mesorectal excision, circumferential tumor margin, and lymph node dissection that may help to better define a subset of stage II rectal cancer patients in which pelvic radiation may be safely omitted.

[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk